Tetraspanins function as regulators of cellular signaling

CM Termini, JM Gillette - Frontiers in cell and developmental biology, 2017 - frontiersin.org
Tetraspanins are molecular scaffolds that distribute proteins into highly organized
microdomains consisting of adhesion, signaling, and adaptor proteins. Many reports have …

Systemic mastocytosis in adults: 2019 update on diagnosis, risk stratification and management

A Pardanani - American journal of hematology, 2019 - Wiley Online Library
Overview Systemic mastocytosis (SM) results from a clonal proliferation of abnormal mast
cells (MCs) in extra‐cutaneous organs. Diagnosis The major criterion is presence of …

The genomic landscape of core-binding factor acute myeloid leukemias

ZJ Faber, X Chen, AL Gedman, K Boggs, J Cheng… - Nature …, 2016 - nature.com
Acute myeloid leukemia (AML) comprises a heterogeneous group of leukemias frequently
defined by recurrent cytogenetic abnormalities, including rearrangements involving the core …

Collaborative efforts driving progress in pediatric acute myeloid leukemia

CM Zwaan, EA Kolb, D Reinhardt… - Journal of clinical …, 2015 - ascopubs.org
Diagnosis, treatment, response monitoring, and outcome of pediatric acute myeloid
leukemia (AML) have made enormous progress during the past decades. Because AML is a …

Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel

U Creutzig, MM van Den Heuvel-Eibrink… - Blood, The Journal …, 2012 - ashpublications.org
Despite major improvements in outcome over the past decades, acute myeloid leukemia
(AML) remains a life-threatening malignancy in children, with current survival rates of∼ …

Molecular correlates of imatinib resistance in gastrointestinal stromal tumors

MC Heinrich, CL Corless, CD Blanke… - Journal of clinical …, 2006 - ascopubs.org
Purpose Gastrointestinal stromal tumors (GISTs) commonly harbor oncogenic mutations of
the KIT or platelet-derived growth factor alpha (PDGFRA) kinases, which are targets for …

Adverse Prognostic Significance of KIT Mutations in Adult Acute Myeloid Leukemia With inv(16) and t(8;21): A Cancer and Leukemia Group B Study

P Paschka, G Marcucci, AS Ruppert… - Journal of Clinical …, 2006 - ascopubs.org
Purpose To analyze the prognostic impact of mutated KIT (mut KIT) in core-binding factor
acute myeloid leukemia (AML) with inv (16)(p13q22) and t (8; 21)(q22; q22). Patients and …

Pediatric AML: from biology to clinical management

JDE De Rooij, CM Zwaan… - Journal of clinical …, 2015 - mdpi.com
Pediatric acute myeloid leukemia (AML) represents 15%–20% of all pediatric acute
leukemias. Survival rates have increased over the past few decades to~ 70%, due to …

Study of clinical outcome and prognosis in pediatric core binding factor-acute myeloid leukemia

J Wu, AD Lu, LP Zhang, YX Zuo… - Zhonghua xue ye xue za …, 2019 - europepmc.org
Objective: To analyze the clinical outcome and the prognostic factor in pediatric patients with
core binding factor-acute myeloid leukemia (CBF-AML). Methods: A total of 121 newly …

[HTML][HTML] Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations

C Bodemer, O Hermine, F Palmérini, Y Yang… - Journal of Investigative …, 2010 - Elsevier
Adult mastocytosis is an incurable clonal disease associated with c-KIT mutations, mostly in
exon 17 (D 816 V). In contrast, pediatric mastocytosis often spontaneously regresses and is …